位置:首页 > 蛋白库 > SC5A4_HUMAN
SC5A4_HUMAN
ID   SC5A4_HUMAN             Reviewed;         659 AA.
AC   Q9NY91; O15279;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   03-AUG-2022, entry version 162.
DE   RecName: Full=Solute carrier family 5 member 4 {ECO:0000303|PubMed:13130073};
GN   Name=SLC5A4 {ECO:0000303|PubMed:13130073};
GN   Synonyms=SAAT1, SGLT3 {ECO:0000303|PubMed:13130073};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, LACK OF SUGAR TRANSPORT ACTIVITY,
RP   ACTIVITY REGULATION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Small intestine;
RX   PubMed=13130073; DOI=10.1073/pnas.1733027100;
RA   Diez-Sampedro A., Hirayama B.A., Osswald C., Gorboulev V., Baumgarten K.,
RA   Volk C., Wright E.M., Koepsell H.;
RT   "A glucose sensor hiding in a family of transporters.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:11753-11758(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 73-247.
RC   TISSUE=Brain;
RA   Poppe R., Koepsell H.;
RL   Submitted (DEC-1995) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   FUNCTION, AND ACTIVITY REGULATION.
RX   PubMed=17110502; DOI=10.1124/mol.106.030288;
RA   Voss A.A., Diez-Sampedro A., Hirayama B.A., Loo D.D., Wright E.M.;
RT   "Imino sugars are potent agonists of the human glucose sensor SGLT3.";
RL   Mol. Pharmacol. 71:628-634(2007).
RN   [5]
RP   FUNCTION, LACK OF SUGAR TRANSPORT ACTIVITY, AND MUTAGENESIS OF GLU-457.
RX   PubMed=20421923; DOI=10.1371/journal.pone.0010241;
RA   Bianchi L., Diez-Sampedro A.;
RT   "A single amino acid change converts the sugar sensor SGLT3 into a sugar
RT   transporter.";
RL   PLoS ONE 5:E10241-E10241(2010).
RN   [6]
RP   FUNCTION, LACK OF SUGAR TRANSPORT ACTIVITY, ACTIVITY REGULATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=22766068; DOI=10.1016/j.ejphar.2012.06.033;
RA   Kothinti R.K., Blodgett A.B., North P.E., Roman R.J., Tabatabai N.M.;
RT   "A novel SGLT is expressed in the human kidney.";
RL   Eur. J. Pharmacol. 690:77-83(2012).
CC   -!- FUNCTION: Has electrogenic activity in response to glucose, and may
CC       function as a glucose sensor (PubMed:13130073, PubMed:17110502,
CC       PubMed:20421923, PubMed:22766068). Mediates influx of sodium ions into
CC       the cell but does not transport sugars (PubMed:13130073,
CC       PubMed:22766068). Also potently activated by imino sugars such as
CC       deoxynojirimycin (DNJ) (PubMed:17110502, PubMed:20421923,
CC       PubMed:22766068). {ECO:0000269|PubMed:13130073,
CC       ECO:0000269|PubMed:17110502, ECO:0000269|PubMed:20421923,
CC       ECO:0000269|PubMed:22766068}.
CC   -!- ACTIVITY REGULATION: Inhibited by phlorizin.
CC       {ECO:0000269|PubMed:13130073, ECO:0000269|PubMed:17110502,
CC       ECO:0000269|PubMed:22766068}.
CC   -!- INTERACTION:
CC       Q9NY91; Q8NBJ4: GOLM1; NbExp=3; IntAct=EBI-12409133, EBI-712073;
CC       Q9NY91; Q8N6L0: KASH5; NbExp=3; IntAct=EBI-12409133, EBI-749265;
CC       Q9NY91; Q96HJ5: MS4A3; NbExp=3; IntAct=EBI-12409133, EBI-12806656;
CC       Q9NY91; Q96Q45-2: TMEM237; NbExp=3; IntAct=EBI-12409133, EBI-10982110;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:13130073,
CC       ECO:0000305|PubMed:17110502, ECO:0000305|PubMed:20421923,
CC       ECO:0000305|PubMed:22766068}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Expressed in skeletal muscle, where it may localize
CC       to the neuromuscular junction (at protein level) (PubMed:13130073).
CC       Expressed in small intestine where it may localize to cholinergic
CC       neurons of the submucosal plexus and myenteric plexus (at protein
CC       level) (PubMed:13130073). Detected in kidney (at protein level)
CC       (PubMed:22766068). {ECO:0000269|PubMed:13130073,
CC       ECO:0000269|PubMed:22766068}.
CC   -!- SIMILARITY: Belongs to the sodium:solute symporter (SSF) (TC 2.A.21)
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ133127; CAB81772.1; -; mRNA.
DR   EMBL; AL008723; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; U41897; AAB61732.1; -; mRNA.
DR   CCDS; CCDS13903.1; -.
DR   RefSeq; NP_055042.1; NM_014227.2.
DR   AlphaFoldDB; Q9NY91; -.
DR   SMR; Q9NY91; -.
DR   BioGRID; 112418; 35.
DR   IntAct; Q9NY91; 4.
DR   STRING; 9606.ENSP00000266086; -.
DR   BindingDB; Q9NY91; -.
DR   ChEMBL; CHEMBL1770047; -.
DR   DrugCentral; Q9NY91; -.
DR   TCDB; 2.A.21.3.18; the solute:sodium symporter (sss) family.
DR   GlyGen; Q9NY91; 1 site.
DR   iPTMnet; Q9NY91; -.
DR   PhosphoSitePlus; Q9NY91; -.
DR   BioMuta; SLC5A4; -.
DR   DMDM; 17433306; -.
DR   jPOST; Q9NY91; -.
DR   MassIVE; Q9NY91; -.
DR   PaxDb; Q9NY91; -.
DR   PeptideAtlas; Q9NY91; -.
DR   PRIDE; Q9NY91; -.
DR   ProteomicsDB; 83196; -.
DR   Antibodypedia; 11228; 109 antibodies from 24 providers.
DR   DNASU; 6527; -.
DR   Ensembl; ENST00000266086.6; ENSP00000266086.3; ENSG00000100191.6.
DR   GeneID; 6527; -.
DR   KEGG; hsa:6527; -.
DR   MANE-Select; ENST00000266086.6; ENSP00000266086.3; NM_014227.3; NP_055042.1.
DR   UCSC; uc003ami.4; human.
DR   CTD; 6527; -.
DR   DisGeNET; 6527; -.
DR   GeneCards; SLC5A4; -.
DR   HGNC; HGNC:11039; SLC5A4.
DR   HPA; ENSG00000100191; Tissue enriched (intestine).
DR   MIM; 618633; gene.
DR   neXtProt; NX_Q9NY91; -.
DR   OpenTargets; ENSG00000100191; -.
DR   PharmGKB; PA35904; -.
DR   VEuPathDB; HostDB:ENSG00000100191; -.
DR   eggNOG; KOG2349; Eukaryota.
DR   GeneTree; ENSGT00940000160846; -.
DR   HOGENOM; CLU_018808_9_2_1; -.
DR   InParanoid; Q9NY91; -.
DR   OMA; CVKHCGI; -.
DR   OrthoDB; 243316at2759; -.
DR   PhylomeDB; Q9NY91; -.
DR   TreeFam; TF352855; -.
DR   PathwayCommons; Q9NY91; -.
DR   Reactome; R-HSA-189200; Cellular hexose transport.
DR   SignaLink; Q9NY91; -.
DR   BioGRID-ORCS; 6527; 8 hits in 1060 CRISPR screens.
DR   ChiTaRS; SLC5A4; human.
DR   GeneWiki; SLC5A4; -.
DR   GenomeRNAi; 6527; -.
DR   Pharos; Q9NY91; Tchem.
DR   PRO; PR:Q9NY91; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; Q9NY91; protein.
DR   Bgee; ENSG00000100191; Expressed in duodenum and 87 other tissues.
DR   Genevisible; Q9NY91; HS.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005412; F:glucose:sodium symporter activity; IBA:GO_Central.
DR   GO; GO:0006814; P:sodium ion transport; IBA:GO_Central.
DR   Gene3D; 1.20.1730.10; -; 1.
DR   InterPro; IPR038377; Na/Glc_symporter_sf.
DR   InterPro; IPR001734; Na/solute_symporter.
DR   InterPro; IPR018212; Na/solute_symporter_CS.
DR   Pfam; PF00474; SSF; 1.
DR   TIGRFAMs; TIGR00813; sss; 1.
DR   PROSITE; PS00456; NA_SOLUT_SYMP_1; 1.
DR   PROSITE; PS00457; NA_SOLUT_SYMP_2; 1.
DR   PROSITE; PS50283; NA_SOLUT_SYMP_3; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Glycoprotein; Ion transport; Membrane; Reference proteome;
KW   Sodium; Sodium transport; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..659
FT                   /note="Solute carrier family 5 member 4"
FT                   /id="PRO_0000105376"
FT   TOPO_DOM        1..28
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        29..47
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        48..64
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        65..85
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        86..105
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        106..126
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        127..171
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        172..191
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        192..208
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        209..229
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        230..270
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        271..291
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        292..314
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        315..334
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        335..423
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        424..443
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        444..455
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        456..476
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        477..526
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        527..547
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        548..637
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        638..658
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   REGION          573..592
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        248
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VARIANT         4
FT                   /note="T -> M (in dbSNP:rs16990065)"
FT                   /id="VAR_052489"
FT   VARIANT         46
FT                   /note="A -> T (in dbSNP:rs2235171)"
FT                   /id="VAR_021997"
FT   MUTAGEN         457
FT                   /note="E->Q: Confers sugar transport activity not found in
FT                   the wild-type protein. Increased sensitivity to inhibitor
FT                   phlorizin."
FT                   /evidence="ECO:0000269|PubMed:20421923"
FT   CONFLICT        76
FT                   /note="A -> V (in Ref. 3; AAB61732)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        106
FT                   /note="S -> P (in Ref. 3; AAB61732)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        243
FT                   /note="V -> I (in Ref. 3; AAB61732)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   659 AA;  72456 MW;  F8A34AED648B523A CRC64;
     MASTVSPSTI AETPEPPPLS DHIRNAADIS VIVIYFLVVM AVGLWAMLKT NRGTIGGFFL
     AGRDMAWWPM GASLFASNIG SNHYVGLAGT GAASGVATVT FEWTSSVMLL ILGWIFVPIY
     IKSGVMTMPE YLKKRFGGER LQVYLSILSL FICVVLLISA DIFAGAIFIK LALGLDLYLA
     IFILLAMTAV YTTTGGLASV IYTDTLQTII MLIGSFILMG FAFNEVGGYE SFTEKYVNAT
     PSVVEGDNLT ISASCYTPRA DSFHIFRDAV TGDIPWPGII FGMPITALWY WCTNQVIVQR
     CLCGKDMSHV KAACIMCAYL KLLPMFLMVM PGMISRILYT DMVACVVPSE CVKHCGVDVG
     CTNYAYPTMV LELMPQGLRG LMLSVMLASL MSSLTSIFNS ASTLFTIDLY TKMRKQASEK
     ELLIAGRIFV LLLTVVSIVW VPLVQVSQNG QLIHYTESIS SYLGPPIAAV FVLAIFCKRV
     NEQGAFWGLM VGLAMGLIRM ITEFAYGTGS CLAPSNCPKI ICGVHYLYFS IVLFFGSMLV
     TLGISLLTKP IPDVHLYRLC WVLRNSTEER IDIDAEEKSQ EETDDGVEED YPEKSRGCLK
     KAYDLFCGLQ KGPKLTKEEE EALSKKLTDT SERPSWRTIV NINAILLLAV VVFIHGYYA
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024